Detalhe da pesquisa
1.
HA-1-targeted T cell receptor (TCR) T cell therapy for recurrent leukemia after hematopoietic stem cell transplantation.
Blood
; 2024 Apr 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-38683966
2.
Factors associated with outcomes after a second CD19-targeted CAR T-cell infusion for refractory B-cell malignancies.
Blood
; 137(3): 323-335, 2021 01 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-32967009
3.
Survivorship after Autologous Hematopoietic Cell Transplantation for Lymphoma and Multiple Myeloma: Late Effects and Quality of Life.
Biol Blood Marrow Transplant
; 26(2): 407-412, 2020 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-31605822
4.
Late Events after Treatment with CD19-Targeted Chimeric Antigen Receptor Modified T Cells.
Biol Blood Marrow Transplant
; 26(1): 26-33, 2020 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31419568
5.
Patient-Reported Neuropsychiatric Outcomes of Long-Term Survivors after Chimeric Antigen Receptor T Cell Therapy.
Biol Blood Marrow Transplant
; 26(1): 34-43, 2020 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31605820
6.
Bone Health Management After Hematopoietic Cell Transplantation: An Expert Panel Opinion from the American Society for Transplantation and Cellular Therapy.
Biol Blood Marrow Transplant
; 26(10): 1784-1802, 2020 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-32653624
7.
Rates and Risk Factors for Post-Traumatic Stress Disorder Symptomatology among Adult Hematopoietic Cell Transplant Recipients and Their Informal Caregivers.
Biol Blood Marrow Transplant
; 25(1): 145-150, 2019 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30098393
8.
Use of Chimeric Antigen Receptor T Cell Therapy in Clinical Practice for Relapsed/Refractory Aggressive B Cell Non-Hodgkin Lymphoma: An Expert Panel Opinion from the American Society for Transplantation and Cellular Therapy.
Biol Blood Marrow Transplant
; 25(12): 2305-2321, 2019 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-31446199
9.
Clinical Utilization of Chimeric Antigen Receptor T Cells in B Cell Acute Lymphoblastic Leukemia: An Expert Opinion from the European Society for Blood and Marrow Transplantation and the American Society for Blood and Marrow Transplantation.
Biol Blood Marrow Transplant
; 25(3): e76-e85, 2019 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-30576834
10.
Reversal of Low Donor Chimerism after Hematopoietic Cell Transplantation Using Pentostatin and Donor Lymphocyte Infusion: A Prospective Phase II Multicenter Trial.
Biol Blood Marrow Transplant
; 24(2): 308-313, 2018 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-29032276
11.
Quality of Life of Caregivers of Hematopoietic Cell Transplant Recipients.
Biol Blood Marrow Transplant
; 24(11): 2271-2276, 2018 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-29935213
12.
Success of Immunosuppressive Treatments in Patients with Chronic Graft-versus-Host Disease.
Biol Blood Marrow Transplant
; 24(3): 555-562, 2018 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-29133250
13.
Central nervous system involvement in acute myeloid leukemia patients undergoing hematopoietic cell transplantation.
Biol Blood Marrow Transplant
; 21(3): 546-51, 2015 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-25545726
14.
Central nervous system relapse in adults with acute lymphoblastic leukemia after allogeneic hematopoietic stem cell transplantation.
Biol Blood Marrow Transplant
; 20(11): 1767-71, 2014 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-25017763
15.
Treosulfan, fludarabine, and 2-Gy total body irradiation followed by allogeneic hematopoietic cell transplantation in patients with myelodysplastic syndrome and acute myeloid leukemia.
Biol Blood Marrow Transplant
; 20(4): 549-55, 2014 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-24440648
16.
Donor lymphocyte infusion for relapsed hematological malignancies after allogeneic hematopoietic cell transplantation: prognostic relevance of the initial CD3+ T cell dose.
Biol Blood Marrow Transplant
; 19(6): 949-57, 2013 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-23523892
17.
Maintenance therapy with tyrosine kinase inhibitors after transplant in patients with chronic myeloid leukemia.
J Natl Compr Canc Netw
; 11(3): 308-15, 2013 Mar 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-23486457
18.
Severe cytokine release syndrome is associated with hematologic toxicity following CD19 CAR T-cell therapy.
Blood Adv
; 6(7): 2055-2068, 2022 04 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-34666344
19.
Targeting an alternate Wilms' tumor antigen 1 peptide bypasses immunoproteasome dependency.
Sci Transl Med
; 14(631): eabg8070, 2022 02 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-35138909
20.
Antibodies against vaccine-preventable infections after CAR-T cell therapy for B cell malignancies.
JCI Insight
; 6(11)2021 06 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-33914708